Hengyuan Refining Company Bhd (4324)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 4.110 |
|---|---|
| 52-week range | 0.720 – 4.680 |
| Return, 1 month / 3 months | −5.5% / +209.3% |
| Return, 1 year / 3 years | +358.0% / +56.1% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 84.0% |
| Worst drawdown (1 year) | -46.8% |
| Average daily value traded | 26.83M MYR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hengyuan Refining Company operates an oil refinery at Port Dickson in Malaysia, where it processes crude oil into refined petroleum products. Its output includes fuels such as gasoline, diesel, jet fuel and liquefied petroleum gas, along with other refined products supplied to customers in Malaysia and nearby markets. The company serves fuel distributors, industrial users and other buyers of refined petroleum products, and its operations centre on the refinery and associated storage and marine facilities at the coastal site.
Hengyuan Refining Company Bhd trades under the code 4324 on the Bursa Malaysia in Malaysia, with its price quoted in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hengyuan Refining Company Bhd (4324) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 4.110 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 199 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 358.0% and over the last three months it rose 209.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 140.7% | ||
| From 52-week high | -9.5% | ||
| Momentum | 100 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 209.3% | ||
| 6-month return | 262.1% | ||
| 12-month return, skipping the last month | 384.8% | ||
| Stability (higher is calmer) | 16 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 84.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.8% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 26.83M MYR | ||
| Zero-volume days | 1.7% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | −5.5% |
| 3 months | +209.3% |
| 6 months | +262.1% |
| 1 year | +358.0% |
| 3 years | +56.1% |
| 5 years | +14.7% |
Signals
| 50-day / 200-day average | 3.327 / 1.708 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.216 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | MYR 0.1000 |
| 30 Sep 2022 | MYR 0.1000 |
| 22 Mar 2021 | MYR 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.